Glycated hemoglobin and liver disease in diabetes mellitus

Wiener Medizinische Wochenschrift

Volumn 155, Issue 17-18, 2005, Pages 411-415

  Schnedl, Wolfgang J ^a,b   Wallner, Sandra J ^a   Piswanger, Claudia ^a   Krause, Robert ^a   Lipp, Rainer W ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Department of Medicine ^*  (Austria)

Author keywords

Diabetes mellitus; Fructosamine; Glycated hemoglobin; Glycation; HbA1c; Liver cirrhosis; Liver disease

Indexed keywords

FRUCTOSAMINE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

DISEASE CONTROL; DISEASE SEVERITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIVER CIRRHOSIS; LIVER DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; REVIEW;

CAUSE OF DEATH; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SURVIVAL RATE;

EID: 26944494556     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-005-0210-4     Document Type: Review

References (57)

1. Tolman KG, Fonseca V, Tan MH, Dalpiaz A (2004) Narrative review: hepatobiliary disease in type 2 diabetes mellitus. Ann Intern Med 141: 946-956
2. Lahousen T, Hegenbarth K, Ille R, et al (2004) Determination of glycated haemoglobin in patients with advanced liver disease. World J Gastroenterol 10: 2284-2286
3. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, Mcdonald JM, Parrot M (2002) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48: 436-472
4. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
5. Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 2817: 2005-2012
6. Cohen RM, Holmes YR, Chenier TC, Joiner CH (2003) Discordance between HbA1c and fructosamine. Diabetes Care 26: 163-167
7. Trenti T, Cristiani A, Cioni G, Pentore R, Mussini C, Ventura E (1990) Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis. Ric Clin Lab 20: 261-267
8. Cacciatore L, Cozzolino G, Giardina MG, et al (1988) Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease. Diabetes Res 7: 185-188
9. Nomura Y, Nanjo K, Miyano M, et al. (1989) Hemoglobin A1 in cirrhosis of the liver. Diabetes Res 11: 177-180
10. De Marco R, Locatelli F, Zoppini G, Verlato G, Bonora E, Muggeo M (1999) Cause specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 22: 756-761
11. Radziuk J, Pye S (2001) Hepatic glucose uptake, glyconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 17: 250-272
12. Paccioni M, Nicoletti C, Caminiti M, et al (2000) Association of obesity and type II diabetes mellitus as a risk factor for gallstones. Dig Dis Sci 45: 2002-2006
13. Petrides AS, DeFronzo RA (1989) Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabetes Metab Rev 5: 691-709
14. Ludwig J, Viggiano TR, Mcgill DB, Oh BJ. (1980) Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438
15. El-Serag HB, Everhart JE (2002) Diabetes increases the risk of acute hepatic failure. Gastroenterology 122: 1822-1828
16. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231
17. El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126: 460-468
18. Simo R, Hernandez C, Genesca J, et al (1996) High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 19: 998-1000
19. Knobler H, Stagnaro-Green A, Wallenstein S, et al (1998) Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 26: 30-33
20. Baig NA, Herrine SK, Rubin R (2001) Liver disease and diabetes mellitus. Clin Lab Med 21: 193-207
21. Maruyama S, Hirayama C, Yamamoto S, et al (2001) Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 138: 332-337
22. Jiao Y, Okumiya T, Saibara T, Park K, Sasaki M (1998) Abnormally decreased HbA1c can be assessed with erythrocyte creatine in patients with shortened erythrocyte age. Diabetes Care 21: 1732-1735
23. Tessari P, Barazzoni R, Kiwanuka E, et al (1998) Impairment of albumin and whole body postprandial protein synthesis in compensated liver cirrhosis. Am J Physiol Endocrinol Metab 282: E304-311
24. Sebekova K, Kupcova V, Schinzel R, Heiland A (2002) Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation. J Hepatol 36: 66-71
25. Chitturi S, George J (2002) Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis 22: 169-183
26. Bonkovsy HL, Azar R, Bird S, Szabo G, Banner B (2002) Severe cholestatic hepatitis caused by thiazolidinediones: risk associated with substituting rosiglitazone for troglitazone. Dig Dis Sci 47: 1632-1637
27. Diaz-Gutierrez FL, Ladero JM, Diaz-Rubio M (1998) Acarbose-induced acute severe hepatotoxicity. Am J Gastroenterol 93: 481
28. Saw D, Pitman E, Maung M, Savasatit P, Wasserman D, Yeung CK (1996) Granulomatous hepatitis associated with glyburide. Dig Dis Sci 41 322-335
29. Bailey CJ, Turner RC (1996) Metformin. N Engl J Med 334: 574-579
30. Bajaj M, Suraamornkul S, Pratipanawatr T, et al (2003) Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes 52: 1364-1370
31. Marchesini G, Brizi M, Bianchi G, et al (2001) Metformin in nonalcoholic steatohepatitis. Lancet 358: 893-894
32. Shetty A, Wilson S, Kuo P, et al (2000) Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance. Transplantation 69: 2451-2454
33. American Diabetes Association (2004) Position Statement: tests of glycemia in diabetes. Diabetes Care 27[Suppl 1]: S91-93
34. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE (2001) The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 47: 1985-1992
35. Abraham EC, Huff TA, Cope ND, Wilson JB, Bransome ED, Huisman TH (1978) Determination of glycosylated hemoglobins (HbA1) with a new microcolumn procedure: suitability of the technique of assessing the clinical management of diabetes mellitus. Diabetes 27: 931-937
36. Bry L, Chen PC, Sacks DB (2001) Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 47: 153-163
37. Schnedl WJ, Leitner G, Lipp RW (1997) Glycohemoglobin and glycated proteins in management of diabetes mellitus. Wien Med Wochenschr 147: 359-361
38. Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ (2001) Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev 17: 94-98
39. Panzer S, Kronik G, Lechner K, Bettelheim P, Neumann E, Dudczak RJ (1982) Glycosylated hemoglobin (GHb): an index of red cell survival. Blood 59: 1348-1350
40. Starkman HS, Wacks M, Soeldner JS, Kim A (1983) Effect of acute blood loss on glycosylated hemoglobin determinations in normal subjects. Diabetes Care 6: 291-294
41. Tarim O, Kucukerdogan A, Gunay U, Eralp O, Ercan I (1999) Effects of ion deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int 41: 357-362
42. Davie SJ, Gould BJ, Yudkin JS (1992) Effects of vitamin C on glycosylation of proteins. Diabetes 41: 167-173
43. Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ (1991) Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care 14: 68-72
44. Dix D, Cohen P, Kingsley S, Lea MJ, Senkbeil J, Sexton K (1979) Interference by lactescence in glycohemoglobin analysis. Clin Chem 25: 494-495
45. Flückiger R, Harmon W, Meier W, Loo S, Gabbay KH (1981) Hemoglobin carbamylation in uremia. N Engl J Med 304: 823-827
46. Nathan DM, Francis TB, Palmer JL (1983) Effect of aspirin on determination of glycosylated hemoglobin. Clin Chem 29: 486-489
47. Lahousen T, Roller RE, Lipp RW, Schnedl WJ (2002) Determination of glycated hemoglobins (HbA1c). Wien Klin Wochenschr 114: 301-305
48. Karsegard J, Wicky J, Mensi N, Caulfield A, Philipe J (1997) Spurious glycohemoglobin values associated with hydroxyurea treatment. Diabetes Care 20: 1211-1212
49. Armbruster DA (1987) Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 33: 2153-2163
50. De Franceschi L, Fattovich G, Turrini F, et al (2000) Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C infection: role of membrane oxidative damage. Hepatology 31: 997-1004
51. Rohlfing C, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE (2002) Defining the relationship between plasma glucose and HbA1c. Diabetes Care 25: 275-278
52. Miedema K (2004) Towards worldwide standardization of HbA1c determination. Diabetologia 47: 1143-1148
53. Jeppsson JO, Kobold U, Miedema K, et al (2002) Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40: 78-89
54. Little RR (2000) Recent progress in glycohemoglobin (HbA1c) testing. Diabetes Care 23: 265-266
55. Nakanishi T, Miyazaki A, Iguchi H, Shimizu A (2000) The effect of hemoglobin variants on routine HbA1c measurements: an assessment by a mass spectrometric method. Clin Chem 46: 1689-1692
56. Blincko S, Anzetse J, Edwards R (2000) Measurement of glycated haemoglobin in whole blood by a novel fluorescence quenching assay. Ann Clin Biochem 37: 492-497
57. Sakurabayashi I, Watano T, Yonehara S, et al (2003) New enzymatic assay for glycohemoglobin. Clin Chem 49: 269-274